Загрузка...
1066. Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does β-Lactam class Matter?
BACKGROUND: Vancomycin (VAN) combined with a β-lactam (COMBO) expedites MRSA bacteremia clearance compared with VAN alone. However, the impact of COMBO on persistent MRSA bacteremia (PB) using a contemporary definition of ≥5 days is unknown. There is also no consensus on which β-lactam (BL) should b...
Сохранить в:
| Опубликовано в: : | Open Forum Infect Dis |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6253209/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.903 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|